(December 16, 2019, 6:40 PM EST) -- WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals on Dec. 10 rejected arguments by an e-cigarette manufacturer and an industry trade group that the U.S. Food and Drug Administration violated the Tobacco Control Act and infringed on their First Amendment rights by creating a difficult pathway to premarket authorization and prohibiting free sample distribution of vaping products (Nicopure Labs LLC and Right To Be Smoke-Free Coalition v. Food & Drug Administration, et al., No. 17-5196, D.C. Cir.)....